Impact of antibiotic resistance on the treatment of gram-negative sepsis
- 67 Downloads
Resistance among gram-negative organisms has greatly complicated the care of the septic patient. An understanding of the likely source of infection, the epidemiologic risk of the patient being exposed to an antibiotic-resistant organism, and the specific vulnerabilities of the host are essential to the proper selection of empiric antimicrobial therapy. In this report, we discuss the epidemiology, antibiotic resistance mechanisms, microbiology, treatment strategies, and diagnostic and therapeutic innovations in the approach to the septic patient.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 3.Eisenstein BI, Zaleznik DF: Enterobacteriaceae. In Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone; 1999:2294–2310. This chapter comprehensively reviews the Enterobacteriacae.Google Scholar
- 5.Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Report, Data, Summary from October 1986–April 1998, Issued June 1998. Atlanta: Public Health Service, US Department of Health and Human Services; 1998:1–25. This report analyzes data collected by the NNIS System, an ongoing national surveillance system monitoring nosocomial infection rates, organisms and resistance patterns at more than 250 hospitals. The report can be downloaded from the CDC website at.Google Scholar
- 10.Fridkin SK, Steward CD, Edwards JR, et al.: Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999, 29:245–252. This report analyzes antibiotic resistance patterns and concomitant antimicrobial use at 41 US hospitals.PubMedGoogle Scholar
- 14.Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am J Cardiol 1998, 82:789–793. This is a careful analysis of the pathogens causing infections in US CCUs, from the NNIS database.PubMedCrossRefGoogle Scholar
- 15.Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999. 27:887–892. This is a careful analysis of the pathogens causing infections in US MICUs, from the NNIS database.PubMedCrossRefGoogle Scholar
- 20.Pfaller MA, Jones RN, Doern GV, Kugler K: Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998, 42:1762–1770. These authors investigate antimicrobial resistance patterns for blood stream pathogens from 38 sites in the US and Canada.PubMedGoogle Scholar
- 21.Jones RN, Pfaller MA, Marshall SA, et al.: Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Diagn Microbiol Infect Dis 1997, 29:187–192.PubMedCrossRefGoogle Scholar
- 24.Pfaller MA, Jones RN, Marshall SA, et al.: Inducible amp C β-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 1997, 28:211–219.PubMedCrossRefGoogle Scholar